Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.

Current Pharmacogenomics and Personalized Medicine
Louise WarnichGalen E B Wright

Abstract

South Africa, like many other developing countries, stands to benefit from novel diagnostics and drugs developed by pharmacogenomics guidance due to high prevalence of disease burden in the region. This includes both communicable (e.g., HIV/AIDS and tuberculosis) and non-communicable (e.g., diabetes and cardiovascular) diseases. For example, although only 0.7% of the world's population lives in South Africa, the country carries 17% of the global HIV/AIDS burden and 5% of the global tuberculosis burden. Nobel Peace Prize Laureate Archbishop Emeritus Desmond Tutu has coined the term Rainbow Nation, referring to a land of wealth in its many diverse peoples and cultures. It is now timely and necessary to reflect on how best to approach new genomics biotechnologies in a manner that carefully considers the public health needs and extant disease burden in the region. The aim of this paper is to document and review the advances in pharmacogenomics in South Africa and importantly, to evaluate the direction that future research should take. Previous research has shown that the populations in South Africa exhibit unique allele frequencies and novel genetic variation in pharmacogenetically relevant genes, often differing from other African...Continue Reading

Citations

Oct 23, 2013·Globalization and Health·Emmanuel Peprah, Ambroise Wonkam
Sep 28, 2013·The Journal of Antimicrobial Chemotherapy·M McGrathD F Warner
May 16, 2014·Source Code for Biology and Medicine·Moses P AdogaSimon M Agwale
Oct 2, 2013·Journal of the Neurological Sciences·Janine BlanckenbergJonathan A Carr
Oct 30, 2014·Omics : a Journal of Integrative Biology·Semra ŞardaşVural Özdemir
Oct 25, 2013·International Review of Psychiatry·Andrea Gaedigk
Mar 5, 2014·Expert Opinion on Drug Metabolism & Toxicology·Collet DandaraCollen Masimirembwa
Mar 29, 2014·Expert Opinion on Drug Metabolism & Toxicology·Britt I DrögemöllerLouise Warnich
Jan 15, 2014·Biochimica Et Biophysica Acta·Shabarni GuptaSanjeeva Srivastava
Jun 19, 2014·Health Policy and Planning·Bethany M KaposhiDonald Schopflocher
Jun 17, 2016·Journal of Clinical Psychopharmacology·Saínza GarcíaAna González-Pinto
Apr 6, 2017·Clinical Pharmacology and Therapeutics·M M GutierrezB Ogutu
Nov 10, 2016·Drug Metabolism and Personalized Therapy·Brendon PearceMongi Benjeddou
Feb 6, 2020·Frontiers in Genetics·Bonnie R JoubertKimberly A McAllister
Dec 15, 2015·AIDS Research and Human Retroviruses·Carola R RöhrichLouise Warnich
Jul 1, 2016·Personalized Medicine·Pierre Paul Michel ThomasElena Ambrosino
Apr 9, 2017·Infectious Diseases of Poverty·Takafira Mduluza, Francisca Mutapi
Sep 21, 2018·Frontiers in Oncology·Thomas M DrakeKjetil Søreide
Apr 25, 2021·Clinical Pharmacology and Therapeutics·Larissa WenningJennifer E Hibma

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
acetylation

Software Mentioned

PGENI

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.